← FDA DRUG APPROVALS

FDA ANDA · ANDA070511

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA070511
TYPE
ANDA
ORIGINAL APPROVAL
1986-01-22
LATEST ACTION
1996-04-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE · TABLET · ORAL

Approval history

1996-04-12Labeling · Supplement 16AP
1995-03-01Labeling · Supplement 15AP
1991-08-16Labeling · Supplement 11AP
1991-04-29Manufacturing (CMC) · Supplement 8AP
1991-01-28Manufacturing (CMC) · Supplement 10AP
1989-05-24Labeling · Supplement 7AP
1988-06-20Manufacturing (CMC) · Supplement 3AP
1988-06-20Manufacturing (CMC) · Supplement 4AP
1988-06-20Manufacturing (CMC) · Supplement 5AP
1988-05-02Labeling · Supplement 6AP
1986-01-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →